Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.49B
Enterprise Value6.15B
P/E Ratio31.16
PEG Ratio-0.59
Price/Sales Ratio0.72
Price/Book Ratio1.09
Enterprise/Revenue1.31
Enterprise/EBITDA12.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue4.19B
Revenue/Share15.95
Gross Profit629.45M
EBITDA619.56M
Net Income200.3M
Diluted EPS0.66

Balance Sheet

Total Cash1.52B
Total Cash/Share5.04
Total Debt3.83B
Total Debt/Equity1.2
Current Ratio1.36
Book Value Per Share10.67

Price History

52-Week Change-38.9
52-Week High19.48
52-Week Low9.97
Moving Average 50 Days11.22
Moving Average 200 Days14.14

Statistics

Average Volume7.71M
Shares Outstanding298.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4.34
Payout Ratio1.14
Last Split Factor13:10
Last Split DateMay 28, 2024
AD